SCHEMBL30822384

SCHEMBL30822384

O=CNCCOCCOCCOCCOCC(=O)O

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.40
CYP2C19 P33261 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.34
ADH1B P00325 3/20 0.33
ADH1A P07327 3/20 0.33
ADH7 P40394 3/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
GLP1R P43220 8/20 0.33
BLM P54132 1/20 0.32
PMP22 Q01453 1/20 0.32
HSD17B10 Q99714 1/20 0.32
ADH1C P00326 2/20 0.31
EPHX1 P07099 1/20 0.30
ADH4 P08319 1/20 0.30
TSHR P16473 1/20 0.30
CTH P32929 1/20 0.30
CBS P35520 1/20 0.30
THPO P40225 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22782187 0.90 GLP1R (0.42) EPHX2CYP2C19SMN1; SMN2MEN1KMT2A
SCHEMBL25696346 0.84 SMN1; SMN2 (0.34) SMN1; SMN2ADH1BADH1AADH7MEN1
SCHEMBL26902111 0.84 SMN1; SMN2 (0.34) SMN1; SMN2ADH1BADH1AADH7MEN1
SCHEMBL40122 0.84 SMN1; SMN2 (0.34) SMN1; SMN2ADH1BADH1AADH7MEN1
SCHEMBL27446945 0.84 SMN1; SMN2 (0.34) SMN1; SMN2ADH1BADH1AADH7MEN1
SCHEMBL24798449 0.84 SMN1; SMN2 (0.34) SMN1; SMN2ADH1BADH1AADH7MEN1
SCHEMBL31228430 0.84 SMN1; SMN2 (0.34) SMN1; SMN2ADH1BADH1AADH7MEN1
SCHEMBL27386798 0.83 SMN1; SMN2 (0.38) EPHX2CYP2C19SMN1; SMN2MEN1KMT2A
SCHEMBL7268276 0.83 SMN1; SMN2 (0.38) EPHX2CYP2C19SMN1; SMN2MEN1KMT2A
SCHEMBL30233846 0.83 LMNA (0.40) EPHX2CYP2C19SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117836299-A Novel bifunctional heterocyclic compounds with Bruton tyrosine kinase decomposition via ubiquitin proteasome pathway and uses thereof 韩国化学研究院 2024-04-05 CN disclosed